fluorodeoxyglucose f18 has been researched along with Glioblastoma with Sarcomatous Component in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albert, NL; Bartenstein, P; Brendel, M; Cyran, CC; Herms, J; Ruf, V; Schüller, U; Thon, N; Tonn, JC; Unterrainer, M | 1 |
| Dence, CS; Lewis, JS; Ponde, DE; Welch, MJ | 1 |
| Henderson, R; Ho, LT; Seto, J; Wassef, H | 1 |
| Dolbier, WR; Evans, SM; Freifelder, R; Jenkins, WT; Kachur, AV; Karp, JS; Koch, CJ; Shuman, AL | 1 |
| Bhojani, MS; Chenevert, TL; Galbán, CJ; Johnson, TD; Koeppe, RA; Kuszpit, KK; Lee, KC; Meyer, CR; Moffat, BA; Ranga, R; Rehemtulla, A; Ross, BD; Van Dort, ME | 1 |
| Carson, BS; Guarnieri, M; Jallo, GI; Lee, J; Penno, MB | 1 |
| Fukushi, K; Irie, T; Iwadate, Y; Iyo, M; Namba, H; Sakiyama, S; Sueyoshi, K; Tagawa, M | 1 |
7 other study(ies) available for fluorodeoxyglucose f18 and Glioblastoma with Sarcomatous Component
| Article | Year |
|---|---|
Identification of Distant Metastases From Recurrent Gliosarcoma Using Whole-Body 18F-FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Gliosarcoma; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Recurrence; Whole Body Imaging | 2019 |
Autoradiographic and small-animal PET comparisons between (18)F-FMISO, (18)F-FDG, (18)F-FLT and the hypoxic selective (64)Cu-ATSM in a rodent model of cancer.
Topics: Animals; Autoradiography; Cell Line, Tumor; Coordination Complexes; Copper Radioisotopes; Dideoxynucleosides; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Gliosarcoma; Humans; Metabolic Clearance Rate; Misonidazole; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Inbred F344; Thiosemicarbazones; Tissue Distribution | 2008 |
F-18 FDG PET-CT imaging in recurrent cerebral gliosarcoma.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Gliosarcoma; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2009 |
The radiation response of cells from 9L gliosarcoma tumours is correlated with [F18]-EF5 uptake.
Topics: Animals; Cell Hypoxia; Cell Survival; Fluorodeoxyglucose F18; Gliosarcoma; Male; Radiation Tolerance; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Inbred F344 | 2009 |
Evaluation of treatment-associated inflammatory response on diffusion-weighted magnetic resonance imaging and 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography imaging biomarkers.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Carmustine; Dexamethasone; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Gliosarcoma; Image Processing, Computer-Assisted; Inflammation; Positron-Emission Tomography; Radiopharmaceuticals; Rats | 2010 |
A novel brainstem tumor model: guide screw technology with functional, radiological, and histopathological characterization.
Topics: Animals; Bone Screws; Brain Stem Neoplasms; Cell Line, Tumor; Cognition; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Gliosarcoma; Neoplasm Transplantation; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Random Allocation; Rats; Rats, Inbred F344; Tomography, X-Ray Computed | 2005 |
Glucose and methionine uptake by rat brain tumor treated with prodrug-activated gene therapy.
Topics: Acyclovir; Animals; Antiviral Agents; Biological Transport; Brain Neoplasms; Carbon Radioisotopes; Fluorodeoxyglucose F18; Genetic Therapy; Gliosarcoma; Glucose; Male; Methionine; Prodrugs; Radiopharmaceuticals; Rats; Rats, Inbred F344; Simplexvirus; Thymidine Kinase | 1998 |